BACK TO TOP
KSE100
164,467.20
1428.74
(0.88%)
KSE100PR
49,121.78
426.73
(0.88%)
ALLSHR
99,729.91
842.23
(0.85%)
KSE30
48,442.40
351.39
(0.73%)
KMI30
235,633.52
1656.68
(0.71%)
BKTI
45,328.82
496.19
(1.11%)
OGTI
33,560.53
182.19
(0.55%)
KMIALLSHR
64,521.14
428.23
(0.67%)
PSXDIV20
74,881.37
637.41
(0.86%)
UPP9
58,519.81
327.60
(0.56%)
NITPGI
43,927.79
315.33
(0.72%)
NBPPGI
46,965.30
366.57
(0.79%)
MZNPI
29,572.12
167.99
(0.57%)
JSMFI
41,487.62
142.53
(0.34%)
ACI
20,957.11
201.55
(0.97%)
JSGBKTI
68,602.91
848.17
(1.25%)
HBLTTI
19,280.31
26-10-2026
4.50
(0.02%)
MII30
21,300.70
135.79
(0.64%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.967.16
43.01
(4.65%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Tue, Oct 27, 2026 3:44 PM
REG
DFC
CSF
ODL
Open
929.00
High
978.00
Low
921.00
Volume
66,286
CIRCUIT BREAKER
831.74 — 1,016.57
DAY RANGE
921.00 — 978.00
52-WEEK RANGE ^
821.00 — 1,274.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
924.15
VAR
11.00
HAIRCUT
22.50
P/E Ratio (TTM) **
11.06
1-Year Change * ^
-18.20%
YTD Change * ^
-7.90%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Syed Anis AhmedCEO
Ehsan A. MalikChairperson
Muhammad Usama JamilCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Share Registration Services (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
94,685,256.08
Shares
97,900,302
Free Float
21,183,943
Free Float
21.64%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 27, 2026Financial Results for the Quarter Ended September 30, 2026 View   PDF
Aug 28, 2026Transmission of Quarterly Financial Statements for the Period Ended June 30, 2026 View   PDF
Aug 28, 2026Financial Results for the Half Year Ended June 30 2026 View   PDF
Apr 29, 2026Transmission of Quarterly Report for the Period Ended March 31, 2026 View   PDF
Apr 27, 2026Financial Results for the Quarter Ended March 31, 2026 View   PDF
DateTitleDocument
Oct 20, 2026Board Meeting View   PDF
Aug 20, 2026Board Meeting View   PDF
Apr 30, 2026Certified copy of Resolution passed at the 77th Annual General Meeting View   PDF
Apr 23, 2026Ballott Paper for the Annual General Meeting View   PDF
Apr 20, 2026Board Meeting View   PDF
DateTitleDocument
Jun 10, 2026Re-Appointment of Chairman View   PDF
Jun 10, 2026Re-Appointment of Chief Executive Officer View   PDF
Jun 2, 2026Dissemination of Video Recording Link of Corporate Briefing Session (CBS) 2026 View   PDF
May 25, 2026Revised Presentation of Corporate Briefing Session 2026 View   PDF
May 22, 2026Presentation of Corporate Briefing Session 2026 View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales75,397,73268,177,19755,475,27049,257,722
Profit after Taxation7,966,5005,234,233261,7773,004,186
EPS81.3753.462.6730.69
Q2 2026Q1 2026Q3 2025Q2 2025
Sales20,321,82917,704,72219,819,13419,061,338
Profit after Taxation2,199,9231,940,3081,822,5461,943,499
EPS22.4719.8218.6219.85
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)35.0828.9521.3629.49
Net Profit Margin (%)10.577.680.476.10
EPS Growth (%)52.211,902.25(91.30)(49.65)
PEG0.250.01(1.89)(0.30)

Payouts

Financial Reports